First Solar (FSLR) – Investment Analysts’ Weekly Ratings Changes
Several analysts have recently updated their ratings and price targets for First Solar (NASDAQ: FSLR): 9/9/2026 – First Solar is now covered by Piper Sandler. They set an “overweight” rating and a $260.00 price target on the stock. 9/3/2026 – First Solar was downgraded by Weiss Ratings from “hold (c+)” to “hold (c)”. 8/27/2026 – […]
Weekly Investment Analysts’ Ratings Changes for AON (AON)
AON (NYSE: AON) recently received a number of ratings updates from brokerages and research firms: 9/6/2026 – AON was downgraded by Wall Street Zen from “hold” to “sell”. 9/2/2026 – AON had its “outperform” rating reaffirmed by Evercore Inc. They now have a $423.00 price target on the stock. 9/1/2026 – AON had its “buy” […]
Weekly Investment Analysts’ Ratings Changes for MiMedx Group (MDXG)
Several analysts have recently updated their ratings and price targets for MiMedx Group (NASDAQ: MDXG): 8/29/2026 – MiMedx Group was upgraded by Wall Street Zen from “sell” to “hold”. 8/27/2026 – MiMedx Group was upgraded by Weiss Ratings from “sell (d)” to “sell (d+)”. 8/27/2026 – MiMedx Group had its price target raised by Craig […]
Weekly Investment Analysts’ Ratings Changes for FOX (FOXA)
FOX (NASDAQ: FOXA) recently received a number of ratings updates from brokerages and research firms: 8/25/2026 – FOX had its “buy” rating reaffirmed by Guggenheim. They now have a $85.00 price target on the stock. 8/15/2026 – FOX was upgraded by Wall Street Zen from “hold” to “buy”. 8/14/2026 – FOX had its “buy” rating […]
RCM Technologies (RCMT) – Investment Analysts’ Recent Ratings Changes
RCM Technologies (NASDAQ: RCMT) recently received a number of ratings updates from brokerages and research firms: 8/24/2026 – RCM Technologies was upgraded by Zacks Research from “hold” to “strong-buy”. 8/17/2026 – RCM Technologies had its price target raised by B. Riley Financial, Inc. from $40.00 to $45.00. They now have a “buy” rating on the […]
Intuitive Surgical (ISRG) – Investment Analysts’ Recent Ratings Changes
Intuitive Surgical (NASDAQ: ISRG) has recently received a number of price target changes and ratings updates: 8/21/2026 – Intuitive Surgical had its “overweight” rating reaffirmed by Piper Sandler. 8/15/2026 – Intuitive Surgical was downgraded by Wall Street Zen from “buy” to “hold”. 8/14/2026 – Intuitive Surgical had its “hold (c)” rating reaffirmed by Weiss Ratings. […]
Ulta Beauty (ULTA) – Investment Analysts’ Weekly Ratings Changes
Several brokerages have updated their recommendations and price targets on shares of Ulta Beauty (NASDAQ: ULTA) in the last few weeks: 8/31/2026 – Ulta Beauty had its “hold (c)” rating reaffirmed by Weiss Ratings. 8/28/2026 – Ulta Beauty was given a new $631.00 price target by UBS Group AG. 8/28/2026 – Ulta Beauty had its […]
Investment Analysts’ Recent Ratings Changes for EagleRock Land (EROK)
EagleRock Land (NYSE: EROK) has recently received a number of price target changes and ratings updates: 9/1/2026 – EagleRock Land had its price target raised by Piper Sandler from $28.00 to $33.00. They now have an “overweight” rating on the stock. 8/21/2026 – EagleRock Land had its price target raised by The Goldman Sachs Group, […]
Analysts’ Weekly Ratings Changes for PRO Real Estate Investment Trust (PRV.UN)
A number of firms have modified their ratings and price targets on shares of PRO Real Estate Investment Trust (CVE: PRV.UN) recently: 8/14/2026 – PRO Real Estate Investment Trust was upgraded by Canadian Imperial Bank of Commerce from “neutral” to “outperformer”. They now have a C$7.50 price target on the stock, up from C$7.00. 8/14/2026 […]
International Paper (IP) – Investment Analysts’ Weekly Ratings Changes
Several brokerages have updated their recommendations and price targets on shares of International Paper (NYSE: IP) in the last few weeks: 8/25/2026 – International Paper was downgraded by Wall Street Zen from “hold” to “sell”. 8/21/2026 – International Paper was upgraded by Weiss Ratings from “sell (d)” to “sell (d+)”. 8/17/2026 – International Paper was […]
Investment Analysts’ Recent Ratings Changes for Helmerich & Payne (HP)
A number of firms have modified their ratings and price targets on shares of Helmerich & Payne (NYSE: HP) recently: 8/27/2026 – Helmerich & Payne was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”. 8/20/2026 – Helmerich & Payne had its price target raised by Morgan Stanley from $36.00 to $41.00. They now […]
Royal Bank Of Canada (RY) – Investment Analysts’ Recent Ratings Changes
A number of firms have modified their ratings and price targets on shares of Royal Bank Of Canada (NYSE: RY) recently: 8/28/2026 – Royal Bank Of Canada had its “outperform” rating reaffirmed by Scotiabank. 8/21/2026 – Royal Bank Of Canada had its “overweight” rating reaffirmed by Barclays PLC. 8/21/2026 – Royal Bank Of Canada is […]
Investment Analysts’ Recent Ratings Changes for Chord Energy (CHRD)
Chord Energy (NASDAQ: CHRD) has recently received a number of price target changes and ratings updates: 8/13/2026 – Chord Energy had its price target lowered by Wells Fargo & Company from $175.00 to $163.00. They now have an “overweight” rating on the stock. 8/12/2026 – Chord Energy had its price target raised by UBS Group […]
Pulse Biosciences (PLSE) – Investment Analysts’ Recent Ratings Changes
Several analysts have recently updated their ratings and price targets for Pulse Biosciences (NASDAQ: PLSE): 8/29/2026 – Pulse Biosciences was upgraded by Wall Street Zen from “sell” to “hold”. 8/17/2026 – Pulse Biosciences is now covered by Needham & Company LLC. They set a “buy” rating and a $58.00 price target on the stock. 8/10/2026 […]
NIKE (NKE) – Investment Analysts’ Recent Ratings Changes
NIKE (NYSE: NKE) has recently received a number of price target changes and ratings updates: 8/26/2026 – NIKE was given a new $42.00 price target by Truist Financial Corporation. They now have a “hold” rating on the stock. 8/25/2026 – NIKE had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. 8/25/2026 – NIKE had […]
Recent Investment Analysts’ Ratings Changes for Moderna (MRNA)
Several analysts have recently updated their ratings and price targets for Moderna (NASDAQ: MRNA): 8/25/2026 – Moderna was upgraded by Wolfe Research from “underperform” to “peer perform”. 8/24/2026 – Moderna had its price target raised by Barclays PLC from $48.00 to $125.00. They now have an “equal weight” rating on the stock. 8/21/2026 – Moderna […]
last updated on 10 Sep 18:19